I agree, typical announcements are first patient dosed, and begining and end of trial cohorts (not relevant here).
But, because the trial has encountered difficulties in enrolling patients leading to delays, it would be reasoable (if not essential to meet continuous disclosure obligations) to provide some extra updates. Or at least clear information with the quarterly and half yearly reports.
Lets be honest. Each report that cones out - we all skim through looking for that piece of information. That's what current and prospective shareholders deserve to know.
I also agree, Bob seems to care little about shareholder sentiment. Bring on a non-exec chair!
Back to my question. If an online shareholder petition went around, petitioning for a full, clear trial update, would you sign it?
IBX Price at posting:
6.2¢ Sentiment: None Disclosure: Held
